[HTML][HTML] IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy–a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios, R del Pino Algarrada - BMC neurology, 2020 - Springer
Abstract Background IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
[HTML][HTML] IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy–a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios… - BMC …, 2020 - bmcneurol.biomedcentral.com
IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with established efficacy in
the treatment of upper-limb spasticity in adults. This retrospective case series in a university …
the treatment of upper-limb spasticity in adults. This retrospective case series in a university …
[PDF][PDF] IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy-a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios, R del Pino Algarrada - 2020 - scholar.archive.org
Abstract Background: IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy-a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
[PDF][PDF] IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy-a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios, R del Pino Algarrada - 2020 - academia.edu
Abstract Background: IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy–a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios… - BMC …, 2020 - search.proquest.com
Background IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
[PDF][PDF] IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy-a retrospective case series focusing on dosing and tolerability
A León-Valenzuela, JS Palacios, R del Pino Algarrada - 2020 - researchgate.net
Abstract Background: IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy-a retrospective case series focusing on dosing and tolerability.
A León-Valenzuela, JS Palacios… - BMC …, 2020 - go.gale.com
Background IncobotulinumtoxinA (Xeomin [R]) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy-a retrospective case series focusing on dosing and tolerability.
A León-Valenzuela, JS Palacios… - BMC …, 2020 - europepmc.org
BACKGROUND: IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy–a retrospective case series focusing on dosing and tolerability
Á León Valenzuela, J Sánchez Palacios… - 2020 - rodin.uca.es
Background: IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …
established efficacy in the treatment of upper-limb spasticity in adults. This retrospective …